The IL23R R381Q Gene Variant Protects against Immune-Mediated Diseases by Impairing IL-23-Induced Th17 Effector Response in Humans-Reference-Cited by-同舟云学术

The IL23R R381Q Gene Variant Protects against Immune-Mediated Diseases by Impairing IL-23-Induced Th17 Effector Response in Humans

Published:2011-02-22 Issue:2 Volume:6 Page:e17160
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Di Meglio Paola,Di Cesare Antonella,Laggner Ute,Chu Chung-Ching,Napolitano Luca,Villanova Federica,Tosi Isabella,Capon Francesca,Trembath Richard C.,Peris Ketty,Nestle Frank O.

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference41 articles.

1. Psoriasis.;FO Nestle;N Engl J Med,2009

2. The interleukin-23 axis in intestinal inflammation.;PP Ahern;Immunol Rev,2008

3. The IL-23/Th17 axis in the immunopathogenesis of psoriasis.;A Di Cesare;J Invest Dermatol,2009

4. IL-23 and autoimmunity: new insights into the pathogenesis of inflammatory bowel disease.;C Abraham;Annu Rev Med,2009

5. Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12.;B Oppmann;Immunity,2000

Cited by 226 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Interleukin 23 receptor: Expression and regulation in immune cells;European Journal of Immunology;2023-10-20

2. Tumor necrosis factor-α inhibitor-related autoimmune disorders;Autoimmunity Reviews;2023-07

3. Single cell and spatial sequencing define processes by which keratinocytes and fibroblasts amplify inflammatory responses in psoriasis;Nature Communications;2023-06-12

4. TYK2 as a novel therapeutic target in psoriasis;Expert Review of Clinical Pharmacology;2023-06-03

5. IL-12 and IL-23 pathway inhibition in inflammatory bowel disease;Nature Reviews Gastroenterology & Hepatology;2023-04-17